Best hospitals in the United States for sarcoma: A data-based care guide

People researching the best hospitals in the United States for sarcoma are usually comparing specialized cancer centers rather than general hospital rankings. Sarcoma is rare, can be misdiagnosed, and often requires coordinated pathology, imaging, surgery, radiation, medical oncology, and rehabilitation expertise. 1

How to interpret the “best” hospitals

No single national ranking measures sarcoma care alone. Broader cancer rankings can identify institutions with substantial oncology infrastructure, but a useful sarcoma comparison also considers annual case volume, subtype expertise, multidisciplinary review, complex surgical capability, clinical trials, and access to pediatric or adult specialists. The National Cancer Institute identifies designated cancer centers and clinical trials as important resources when evaluating rare cancers. 9

Hospital reputation does not guarantee a particular outcome. Sarcoma includes many distinct tumors, including bone sarcomas, soft-tissue sarcomas, Ewing sarcoma, osteosarcoma, rhabdomyosarcoma, and other subtypes. The most appropriate center depends on the diagnosis, tumor location, stage, age, prior treatment, and whether surgery, systemic therapy, radiation, or research participation is being considered. 10

Major national sarcoma programs

MD Anderson Cancer Center in Houston and Memorial Sloan Kettering Cancer Center in New York are frequently identified among the leading U.S. cancer institutions. MD Anderson describes specialized services for bone and soft-tissue sarcomas, while Memorial Sloan Kettering maintains a sarcoma service for both bone and soft-tissue disease. Their broader cancer standing is also notable: a 2026 report placed MD Anderson first and Memorial Sloan Kettering second for U.S. cancer care. 11 12 6

Mayo Clinic is another major option, with sarcoma care across its campuses and specialized teams for children and adults. Its Ewing sarcoma program describes pediatric oncology, orthopedic surgery, pediatric surgery, radiation oncology, radiology, rehabilitation, nursing, social work, and child-life support working around individualized care. Mayo also reports advanced diagnostic planning, including the use of three-dimensional tumor models for selected surgeries. 4 13

Programs with documented multidisciplinary care

Columbia’s Herbert Irving Comprehensive Cancer Center in New York reports that its specialists see hundreds of sarcoma cases each year. The program describes orthopedic oncologists, reconstructive plastic surgeons, radiation and medical oncologists, pathologists, and radiologists working together, with advanced radiation approaches for complex cases. Columbia also identifies its NCI designation and specialized pathology review as part of its sarcoma-care model. 1

Penn Medicine’s Orthopaedic Oncology Program treats malignant and benign tumors involving bone and soft tissue, including tumors of cartilage, fat, muscle, nerves, tendons, ligaments, and vessels. Penn reports more than 40 years of combined orthopaedic oncology experience and full-time scientists studying sarcoma. The program also describes collaboration with surgeons treating tumors of the spine, chest, abdomen, head, and neck, plus in-person and remote second-opinion pathways. 2

Regional academic alternatives

Patients outside the Northeast and Texas can also evaluate UCLA Health, Stanford Health Care, UCSF Health, Duke Health, Johns Hopkins, Cleveland Clinic, and Cedars-Sinai. The supplied program descriptions identify sarcoma-focused services at these institutions, covering combinations of diagnosis, surgery, radiation, medical oncology, orthopedic oncology, and related specialty care. Johns Hopkins specifically describes coordinated treatment involving surgery, chemotherapy, radiation therapy, and specialist evaluation. 15 16 17 18 19 20

Cedars-Sinai states that its Sarcoma Program is among a small number of California centers providing care for both adults and children in one program. Its reported expertise includes pathology, radiation oncology, surgical care, and clinical research in Ewing sarcoma, rhabdomyosarcoma, osteosarcoma, and other pediatric solid tumors. Such lifespan coverage may be relevant for adolescents and young adults whose care does not fit neatly into adult or pediatric systems. 5

Why hospital volume matters

A 2025 analysis of 71,463 patients in the National Cancer Database examined hospital volume across children, young adults, and adults. The study identified high-volume thresholds of 37 sarcoma cases annually for all ages, five for children and young adults, and 24 for adults. Only 17 of 1,289 hospitals met the all-age threshold, indicating that genuinely high-volume programs represent a small portion of U.S. hospitals. 3

The same study associated treatment at high-volume hospitals with better five-year overall survival. Across all ages, survival was 64.8% at high-volume hospitals compared with 60.0% at lower-volume hospitals. Among adults, the comparison was 63.0% versus 56.8%. Adjusted analyses also found lower mortality hazards at high-volume hospitals across all age categories, although the study shows an association rather than a guarantee for an individual patient. 3

Practical factors, risks, and access barriers

A second opinion or pathology review can be particularly relevant because rare sarcomas are sometimes mistaken for sports injuries, arthritis, benign growths, or other conditions. Selection questions can include whether specialists review outside slides and imaging, how many cases match the specific subtype, which surgeon handles the tumor location, whether pediatric and adult services are available, and whether a relevant clinical trial exists. Trial participation remains subject to study-specific eligibility requirements. 2 9

Travel, insurance coverage, referral procedures, appointment timing, lodging, rehabilitation, and repeated follow-up visits can materially affect feasibility. Clinical trials may involve additional testing, protocol requirements, and uncertainty about benefit. High-volume care is associated with improved outcomes in population data, but treatment can still involve major surgical, radiation, chemotherapy, functional, and recurrence-related risks. A balanced evaluation should therefore compare clinical fit and continuity of care, not reputation alone. 3 4 10

Sources

1. Herbert Irving Comprehensive Cancer Center, Columbia University: Choosing Columbia for Sarcoma Care
2. Penn Medicine: Orthopaedic Oncology
3. Cancer: Exploring hospital volume thresholds for improved sarcoma treatment across different age categories in the United States
4. Mayo Clinic: Ewing sarcoma care at Mayo Clinic
5. Cedars-Sinai: Sarcoma Program, Supporting Care and Research
6. Healio: UT MD Anderson ranked nation’s top cancer hospital
7. Oncology News Central: Annual Oncology Hospital Rankings Released
8. Verywell Health: Top Hospitals for Cancer Care in the U.S.
9. National Cancer Institute: Soft-tissue sarcoma treatment and clinical trials
10. National Cancer Institute: NCI-designated cancer centers
11. The University of Texas MD Anderson Cancer Center: Sarcoma care
12. Memorial Sloan Kettering Cancer Center: Sarcoma care
13. Mayo Clinic: Sarcoma care
14. Dana-Farber Cancer Institute: Sarcoma care
15. Johns Hopkins Medicine: Sarcoma treatment
16. UCLA Health: Sarcoma services
17. Stanford Health Care: Sarcoma care
18. UCSF Health: Sarcoma
19. Duke Health: Sarcoma treatment
20. Cleveland Clinic: Sarcoma